⏱ 3 min read
The steroid sex hormones (testosterone, estradiol, progesterone, dihydrotestosterone, DHEA) are molecules with an extremely broad profile of biological effects that goes far beyond the reproductive system: they regulate muscle mass and bone mineralization, modulate cognitive function and mood, influence carbohydrate and lipid metabolism, and affect the immune response and body fat distribution; their alterations (deficiencies, excesses, imbalances) have varied clinical manifestations and are one of the most frequent reasons for endocrinological evaluation and for nutritional or supplement intervention.
Sex hormones are regulated through the hypothalamic-pituitary-gonadal axis: the hypothalamus releases pulsatile GnRH, which stimulates the pituitary to produce LH and FSH; these gonadotropins act on the testes (in men) and ovaries (in women) to produce testosterone, estradiol, and progesterone; negative feedback from the peripheral hormones on the hypothalamus and pituitary maintains balance. Any intervention that modifies this axis (extreme exercise, severe caloric restriction, chronic stress, certain drugs, hormonally active supplements) can have cascading effects.
Male testosterone falls progressively with age (a decline of 1-2% per year from age 30-40), a process called late-onset hypogonadism or "andropause"; symptoms clinically suggestive of hypogonadism (decreased libido, fatigue, decreased muscle mass and increased fat, cognitive difficulty, depression) are frequent but nonspecific.
Before considering intervention, it is advisable to correct modifiable factors that lower testosterone: - Chronic sleep deprivation (testosterone is produced predominantly during sleep). - Obesity and insulin resistance (they increase the aromatization of testosterone to estrogens). - Chronic stress with high cortisol. - Severe zinc, magnesium, or vitamin D deficiency. - Excessive alcohol and tobacco. - Sedentary lifestyle. - Some drugs (opioids, chronic glucocorticoids, statins in some cases).
Interventions with modest clinical backing: tongkat ali (Eurycoma longifolia) at 200-400 mg/day with data showing increased testosterone in men with low baseline levels; ashwagandha with similar data; correction of vitamin D and zinc deficiency when levels are low; D-aspartic acid with limited data and heterogeneous results. Supplements marketed as "testosterone boosters" (tribulus, fenugreek, generic supplements) have disappointing clinical evidence in men with normal levels.
Exogenous testosterone replacement therapy (TRT) is a pharmacological treatment with a specific indication in biochemically confirmed hypogonadism with concordant symptoms; it has documented benefits but also safety considerations (polycythemia, possible cardiovascular effects, suppression of fertility) that require medical supervision.
The normal menstrual cycle has predictable fluctuations in estradiol (preovulatory peak) and progesterone (luteal phase); perimenopause (typically between ages 40-50) introduces growing variability with associated symptoms; established menopause (12 months without menstruation) marks the definitive end of ovarian function with a sustained fall in sex hormones and characteristic symptoms (hot flashes, night sweats, vaginal dryness, sleep disturbance, mood changes, accelerated loss of bone density).
Nutritional and supplement interventions with backing: - Phytoestrogens (soy isoflavones at 40-80 mg/day, red clover, pueraria mirifica): modest but significant reduction in hot flashes. - Chasteberry (Vitex) for premenstrual syndrome with good clinical backing. - Black cohosh for climacteric symptoms. - Andean maca for libido and climacteric well-being, without acting directly on estrogen receptors. - Vitamin B6 for PMS with modest backing.
Menopausal hormone replacement therapy is a pharmacological treatment with specific indications that requires individualized evaluation of the risk-benefit balance according to context (age, history, symptoms, route of administration).
PCOS is a complex condition with central insulin resistance, ovarian androgen excess, anovulatory cycles, and associated metabolic alterations; baseline nutritional interventions are crucial: improving insulin sensitivity (inositol, myo-inositol + d-chiro-inositol at 4 g/day with good clinical backing, a Mediterranean or low-refined-carbohydrate diet, regular physical exercise), weight control if overweight, and management of androgen excess if it causes hirsutism or alopecia.
The general conclusion: nutritional interventions on sex hormones are usually modest in magnitude, useful as a complement or in mild situations, but they do not replace pharmacological treatment when it is clinically indicated; the combination of an adequate lifestyle (sleep, exercise, healthy weight, stress management) with specific interventions and medical supervision when appropriate is the most solid strategy; commercial supplements with spectacular claims about "hormonal enhancement" usually have disappointing real clinical backing and should be evaluated with skepticism.
Information, not medical advice.